Reduced CR1 levels have been observed in patients with autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, and paracoccidioidomycosis, potentially altering the binding site of the immune complex [34]. Here, CR1 is linked to paracoccidioidomycosis.